Ultraquin 4% Hydroquinone Gel USP
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Hydroquinone | 4 % (p/p) |
Non-medicinal ingredients
Benzophenone, Ethylhexyl Dimethyl PABA, alcool dénaturé, propylèneglycol, Sodium Bisulfite, C12-15 Alkyl Lactate, Eau purifiée, Carbomer 940, PEG (polyéthylèneglycol), Hydroxyanisole butylé
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 12 years | Not specified | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
To lighten hyperpigmented skin, fade skin discolorations and lighten freckles and "age spots".
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Avoid contact with eyes, mucous membranes and broken or irritated skin. In case of contact, rinse thoroughly with water. Test for sensitivity. Discontinue use and consult a physician in case of skin reactions or a blue-black darkening of the skin. Do not use this product if you are nursing, pregnant or if you intend to become pregnant within 3 months of use. Not for use on children under 12 years of age. Keep out of reach of children. See insert for detailed cautions. To be used only on the advice of a physician. Use only as directed. Do not apply over sunburn or irritated skin. A mild transient stinging or minor redness may occur in people with sensitive skin. To test for sensitivity, before treatment, apply to an area of approximately 1 cm2 of unbroken skin on the inside of the arm. If no irritation occurs within 24 hours, begin treatment for up to 12 weeks. Discontinue use in case of irritation, rash, excessive inflammatory response or if a gradual blue-black darkening of the skin (exogenous ochronosis) occurs. Minor redness is acceptable, but where there is excessive irritation, a rash or other reaction, further treatment is not advised. Severe itching or reddening may occur, in which case the product should be discontinued and the physician notified immediately. The safety of topical hydroquinone use during pregnancy or for children 12 years old or less has not been established. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this product. Close patient supervision is recommended. A bitter taste and anesthetic effect may occur if applied to lips. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure may cause skin re-darkening. Treatment should be limited to relatively small areas of the body at one time. In case of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately. Store at room temperature Note: Slight darkening of the product is normal when exposed to air and does not affect its potency. When this happens, extract a tiny amount of product, clean with a cotton swab and discard prior to use. If entire content becomes brown, discontinue use and consult a physician.
Product record
- Licence holder
- Opella Canada Inc.
- NPN or DIN-HM
- 00626724
- Status
- Inactive licence
- Licence date
- 18 March 2008
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- DIN de transition
Source
Official Health Canada record, licence 00626724
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Ultraquin 4% Hydroquinone Gel USP (Opella Canada Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/00626724-ultraquin-4-hydroquinone-gel-usp, updated 18 March 2008.